• About Norgine
  • Careers
  • Products
  • R & D
  • Finance & Purchasing
  • Business Development
  • Culture
  • Media

Latest News Releases

Norgine and Alfa Wassermann Further Cement their Business Relationship

Norgine is delighted to announce that they have signed a further deal with Alfa Wasserman which gives them the rights to market XIFAXAN® (rifaximin-α) in the Middle East More...


view all news releases

As a leading European specialty pharmaceutical company, Norgine develops, manufactures and markets innovative medicines for the benefit of patients, employees and all other stakeholders


Disclaimer | Contacts